15133-2 |
Anserine+Carnosine+Cysteine+Histidine+Ornithine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15133-2 |
|
|
|
|
Both |
|
|
|
0 |
Amino Acids mixE SerPl Ql |
|
|
|
|
|
Amino Acids mixE; beta -alanyl-N-methylhistidine; Car; Chemistry; Cys; Formiminoglutamic Acidemia; His; Histidinemia; Ordinal; Orn; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15134-0 |
Glutamate+Glutamine+Threonine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15134-0 |
|
|
|
|
Both |
|
|
|
0 |
Glu+Gln+Thr SerPl Ql |
|
|
|
|
|
c707; Chemistry; Gln; Glu; Glu+Gln; Glu+Gln+Thr; Glutamic acid; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thr |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15135-7 |
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15135-7 |
|
|
|
|
Both |
|
|
|
0 |
Amino Acids mixD SerPl Ql |
|
|
|
|
|
(Hcys)2; Amino Acids mixD; Asp; Aspartic acid; Chemistry; CIT; Citr; Gly; Homocyst(e)ine; Homocystin; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Ohpro; OH-Proline; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15136-5 |
Arginine+Argininosuccinate+Lysine+Serine+Taurine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15136-5 |
|
|
|
|
Both |
|
|
|
0 |
Amino Acids mixC SerPl Ql |
|
|
|
|
|
2,6-diaminohexanoic acid; Amino Acids mixC; Arg; Argininosuccinic acid; arginosuccinate; Arginosuccinic acid; ASA; Chemistry; Lys; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tau |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15137-3 |
Alanine+Ethanolamine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Alanine+Ethanolamine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15137-3 |
|
|
|
|
Both |
|
|
|
0 |
Ala+Etn SerPl Ql |
|
|
|
|
|
Ala; Ala+Etn; Alpha alanine; Chemistry; EA; Etn; L-alanine; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15138-1 |
Isoleucine+Leucine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Isoleucine+Leucine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15138-1 |
|
|
|
|
Both |
|
|
|
0 |
Ile+Leu Ur Ql |
|
|
|
|
|
Chemistry; Ile; Ile+Leu; Leu; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15139-9 |
Anserine+Carnosine+Cysteine+Histidine+Ornithine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15139-9 |
|
|
|
|
Both |
|
|
|
0 |
Amino Acids mixE Ur Ql |
|
|
|
|
|
Amino Acids mixE; beta -alanyl-N-methylhistidine; Car; Chemistry; Cys; Formiminoglutamic Acidemia; His; Histidinemia; Ordinal; Orn; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1514-9 |
Glucose^2H post 100 g glucose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL.ROUTINE |
|
1514-9 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 2h p 100 g Glc PO SerPl-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 100 g Glc PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
Changed Class from "CHAL" to "CHAL.ROUTINE" |
0 |
15140-7 |
Arginine+Argininosuccinate+Lysine+Serine+Taurine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15140-7 |
|
|
|
|
Both |
|
|
|
0 |
Amino Acids mixC Ur Ql |
|
|
|
|
|
2,6-diaminohexanoic acid; Amino Acids mixC; Arg; Argininosuccinic acid; arginosuccinate; Arginosuccinic acid; ASA; Chemistry; Lys; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Ser; Tau; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15141-5 |
Beta aminoisobutyrate+Proline |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Beta aminoisobutyrate+Proline [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15141-5 |
|
|
|
|
Observation |
|
|
|
0 |
B-AIB+Pro Ur Ql |
|
|
|
|
|
3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; B-AIB+Pro; Chemistry; Ordinal; Point in time; PR; Pro; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15142-3 |
Alanine+Ethanolamine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Alanine+Ethanolamine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15142-3 |
|
|
|
|
Both |
|
|
|
0 |
Ala+Etn Ur Ql |
|
|
|
|
|
Ala; Ala+Etn; Alpha alanine; Chemistry; EA; Etn; L-alanine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15143-1 |
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15143-1 |
|
|
|
|
Both |
|
|
|
0 |
Amino Acids mixD Ur Ql |
|
|
|
|
|
(Hcys)2; Amino Acids mixD; Asp; Aspartic acid; Chemistry; CIT; Citr; Gly; Homocyst(e)ine; Homocystin; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Ohpro; OH-Proline; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15144-9 |
Glutamate+Glutamine+Threonine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Glutamate+Glutamine+Threonine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15144-9 |
|
|
|
|
Both |
|
|
|
0 |
Glu+Gln+Thr Ur Ql |
|
|
|
|
|
c707; Chemistry; Gln; Glu; Glu+Gln; Glu+Gln+Thr; Glutamic acid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thr; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15145-6 |
Methionine+Tryptophan |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Methionine+Tryptophan [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15145-6 |
|
|
|
|
Both |
|
|
|
0 |
Met+Trp Ur Ql |
|
|
|
|
|
c244; Chemistry; L-tryptophan; Met; Met+Trp; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Trp; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15146-4 |
Acetone |
ACnc |
Body fld |
Pt |
Qn |
|
|
DISCOURAGED |
Acetone [Units/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
15146-4 |
|
|
|
|
Both |
|
|
|
0 |
Acetone Fld-aCnc |
|
|
|
Y |
|
2-propanone; Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Ketone bodies; Me2CO; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
15147-2 |
Acetone |
ARat |
Urine |
24H |
Ord |
|
|
DEPRECATED |
Deprecated Acetone [Units] in 24 hour Urine Qualitative |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
15147-2 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Acetone 24h Ur |
|
|
|
|
|
1 day; 24 hours; 24HR; 2-propanone; Arbitrary rate; DRUG/TOXICOLOGY; Drugs; Ketone bodies; Me2CO; Ordinal; Ql; Qual; Qualitative; Screen; UA; UR; Urn |
2.4 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
15148-0 |
Alkaline phosphatase |
CCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
15148-0 |
|
|
|
|
Both |
|
|
|
0 |
ALP Fld-cCnc |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Fl; Fld; FLU; Fluid; Hepatology; Liver; MSK; Musculoskeletal; Ortho; Orthopedics; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0k |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
15149-8 |
Ammonia |
SCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Ammonia [Moles/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
15149-8 |
|
|
|
|
Both |
|
|
|
0 |
Ammonia Fld-sCnc |
|
|
|
Y |
|
Amm; Ammon; Amon; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Hepatology; Kidney; Level; Liver; Nephrology; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
1515-6 |
Glucose^2H post 100 g glucose PO |
MCnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHAL |
|
1515-6 |
|
|
|
|
|
|
|
|
0 |
Deprecated Glucose 2H p 100 g Glc PO Ser |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p 100 g Glc PO; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
15150-6 |
Anisocytosis |
PrThr |
Bld |
Pt |
Ord |
Automated count |
|
ACTIVE |
Anisocytosis [Presence] in Blood by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
15150-6 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Anisocytosis Bld Ql Auto |
|
|
|
|
|
Aniso; Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15151-4 |
Aspergillus fumigatus 3 Ab |
PrThr |
Ser |
Pt |
Ord |
Immune diffusion |
|
ACTIVE |
Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
15151-4 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
A fumigatus3 Ab Ser Ql ID |
|
|
|
|
|
A fumigatus; A fumigatus3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Fum; ID; III; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; m003; m3; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15152-2 |
Bilirubin.glucuronidated |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bilirubin.conjugated [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
15152-2 |
|
|
|
|
Both |
|
|
|
0 |
Bilirub Conj SerPl-mCnc |
|
|
|
Y |
|
Bc; Bili; Bilirub Conj; Bilirubin conjugated; Bilirubin glucuronides; Bilirubins; Billirubin; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15153-0 |
Bilirubin.non-glucuronidated |
MCnc |
Ser/Plas |
Pt |
Qn |
Differential light absorption |
|
DEPRECATED |
Deprecated Indirect bilirubin [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
15153-0 |
|
Differential light absorption |
|
|
|
|
|
|
0 |
Deprecated Bilirub Indirect SerPl-mCnc |
|
|
|
Y |
|
Absorp; Bili; Bilirub Indirect; Bilirubin indirect; Bilirubin non-conjugated; Bilirubin primary; Bilirubin unconjugated; Bilirubins; Billirubin; Bu; Chemistry; Diff; Differl; Differn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL |
2.7 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
15154-8 |
Blasts |
PrThr |
Bld |
Pt |
Ord |
Automated count |
|
ACTIVE |
Blasts [Presence] in Blood by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
15154-8 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Blasts Bld Ql Auto |
|
|
|
|
|
Auto; Automated detection; Blast; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15155-5 |
Calcium |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Calcium [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
15155-5 |
|
|
|
|
Both |
|
|
|
0 |
Calcium Fld-mCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Ca; Cal; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |